The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Aug 17, 2026
Snapshot (as of Aug 17, 2026): Labcorp Holdings Inc. (LH) pays a $2.88 annual dividend ($0.72 quarterly), yielding 0.89% at $324.41/share. Next ex-dividend date 2026-08-28. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 0.89%
Annual Dividend: $2.88 per share
Payout Ratio: 23.9%
Ex-Dividend Date: 2026-08-28
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 10
Labcorp Holdings Inc. dividend pays $2.88 per share annually, backed by a business built on diagnostic laboratory services for healthcare providers, pharmaceutical firms, and patients. The current yield sits at 0.93%, paid quarterly, with the next ex-dividend date on August 28, 2026. Each quarterly payment comes to $0.72 per share. With a beta of 0.861, LH stock moves less than the broader market, which suits income investors who prioritize lower volatility over a high headline yield.
Labcorp Holdings Inc. pays out 23.9% of earnings as dividends, a payout ratio classified as conservative (below 40%). That low payout leaves substantial room to sustain the dividend even if earnings come under pressure, and the company's role providing diagnostic laboratory services to healthcare facilities and pharmaceutical firms points to recurring, demand-driven revenue. The main data-supported pressure on Labcorp Holdings Inc. dividend safety is the limited four-year streak of consecutive increases, which means the growth commitment is still relatively short compared to longer-tenured payers.
Labcorp Holdings Inc. dividend history shows a CAGR of 6.3% per year from 1992 to 2025. The per-share dividend grew from $0.38 to $2.88 over that span (2026 is a partial year and excluded from this calculation). The largest annual increase in the available window was 657.9% in 2023, which reflects a resumption of payments rather than organic growth from a prior base.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +10.1% | $2.16 (2022) | $2.88 (2025) |
LH stock fits dividend investors who want a low-payout, low-volatility holding in the healthcare diagnostics space rather than a high current income stream. The yield is low (below 2%), currently at 0.93%, which sits just above the five-year average of 0.87% — so buyers are not paying a premium relative to LH's own history. The 23.9% payout ratio is the defining strength here: it leaves the dividend well-covered and room for future increases. The trade-off is straightforward. Income investors get a conservatively funded dividend with four consecutive years of increases, but the yield alone will not carry an income-focused portfolio.
| Payment Date | Amount per Share |
|---|---|
| 2026-08-28 | $0.7200 |
| 2026-05-29 | $0.7200 |
| 2026-02-27 | $0.7200 |
| 2025-11-26 | $0.7200 |
| 2025-08-28 | $0.7200 |
| 2025-05-29 | $0.7200 |
| 2025-02-27 | $0.7200 |
| 2024-11-26 | $0.7200 |
| 2024-08-29 | $0.7200 |
| 2024-05-24 | $0.7200 |
| Year | Total Dividends |
|---|---|
| 2026 | $2.1600 |
| 2025 | $2.8800 |
| 2024 | $2.8800 |
| 2023 | $2.8800 |
| 2022 | $2.1600 |
Project income from LH with the LH dividend calculator or track your full portfolio with the dividend tracker.